Biomedical research institutes including university medical centres select from high potential research projects. Health charities may participate in the consortium.
Selected projects are transferred into spin-off companies.
Research institute partners commit to co-funding.
Human+ is invited to co-fund the new company.
If the project fulfils the Human+ requirements, EATRIS* performs technical and translational feasibility assessments including the likelihood of reimbursement by health insurers.
If the assessments and successive investment decision are positive, Human+ commits to the spin-off company.
Together with the co-funders, Human+ ensures inclusion of the research expertise and appropriate company management from the start.
(*) EATRIS is the European Infrastructure for Translational Medicine. Website EATRIS.